Delivery Order SPE2DB22D3401-SPE2DB25FT4WK
Award Date
6/25/25
Potential Completion Date
7/17/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.88, is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025 and was awarded on February 27, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,421.76 firm-fixed-price contract is for the supply of RYANODEX 250 MG VIALS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and was awarded on February 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,448.96, is for the supply of RYANODEX 250MG VIAL 1S, a medical product. The contract is a firm fixed-price delivery order with a performance period ending on May 14, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a ceiling value of $3,210.88 and a period of performance through June 4, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a ceiling value of $1,605.44. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product RYANODEX 250MG VIAL 1S, with a total ceiling value of $5,958.56 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The order is for 4,565,338,781 units of the pharmaceutical product RYANODEX 250 MG VIALS, with a ceiling value of $2,979.28. The contract is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a potential value of $2,979.28 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RYANODEX 250 MG VIALS. The contract has a potential value of $1,489.64 and a completion date of March 14, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4567771250 RYANODEX 250 MG VIALS. The contract has a ceiling value of $3,210.88 and a period of performance through April 8, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains an Indefinite Delivery Contract (IDC) valued at...